In this qualitative study, the authors asked respondents with multiple chemical sensitivity (MCS) in an open-ended question how having the condition affected their identities. Authors then examined responses for themes, which they discuss within the framework of critical theory. Emergent themes included loss of a stable, familiar personality, loss of self-positioning, emotional suppression to meet others’ expectations, redesigning the planned life, forced growth, struggling with support, discovering the spiritual self, and identity reconsolidation. The authors compare findings with published works on adjustment to chronic illness and other delegitimized illnesses, find them to be fairly congruent, and then discuss problems regarding cultural acceptance of MCS as a condition caused by chemical exposure.
Altschuler, J. (1997). Working with chronic illness: A family approach. London: McMillan.
2.
Anderson, J. S., & Ferrans, C. E. (1997). The quality of life of persons with chronic fatigue syndrome. Journal of Nervous and Mental Disease, 185(6), 359-367.
3.
Åsbring, P., & Närvanen, A. (2002). Women’s experiences of stigma in relation to chronic fatigue syndrome and fibromyalgia. Qualitative Health Research, 12, 148-160.
4.
Ashford, N. A., & Miller, C. S. (1994). Chemical sensitivity: An emerging public health and environmental problem. Environmental Impact Assessment Review, 14, 451-467.
5.
Ashford, N. A., & Miller, C. S. (1998). Chemical exposures: Low levels and high stakes (2nd ed.). New York: Van Nostrand Reinhold.
6.
Baker, E. L. (1994). A review of recent research on health effects of human occupational exposure to organic solvents: A critical review. Journal of Occupational Medicine, 36, 1079-1092.
7.
Ballweg, M. L. (1995). Psychologizing of endometriosis. Clinical Consultations in Obstetrics and Gynecology, 7, 214-221.
8.
Bell, I. R. (1992). Neuropsychiatric and biopsychosocial mechanisms in multiple chemical sensitivity: An olfactory-limbic model. In National Research Council (Ed.), Multiple chemical sensitivities: Addendum to biologic markers in immunotoxicology (pp. 89-108). Washington, DC: National Academy Press.
9.
Bell, I. R., Peterson, J. M., & Schwartz, G. E. (1995). Medical histories and psychological profiles of middle-aged women with and without self-reported illness from environmental chemicals. Journal of Clinical Psychiatry, 56(4), 151-160.
10.
Berkson, J. B. (1996). A canary’s tale. Baltimore, MD: Author.
11.
Buchwald, D., & Garrity, D. (1994). Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Archives of Internal Medicine, 154, 2049-2053.
12.
Bury, M. (1982). Chronic illness as biographical disruption. Sociology of Health & Illness, 4, 167-182.
13.
Caress, S., & Steinemann, A. (2003). A review of a two-phase population study of multiple chemical sensitivities. Environmental Health Perspectives, 111, 1490-1497.
14.
Charmaz, K. (1983). Loss of self: A fundamental form of suffering in the chronically ill. Sociology of Health & Illness, 5, 168-195.
15.
Chircop, A., & Keddy, B. (2003). Women living with environmental illness. Health Care for Women International, 24, 371-383.
16.
Colborn, T., Dumanoski, D., & Myers, J. P. (1997). Our stolen future: Are we threatening our fertility, intelligence, and survival?—A scientific detective story. New York: Penguin.
17.
Comstock, D. F. (1994). A method for critical research. In M. Martin & L. C. McIntyre (Eds.), Readings in the philosophy of social science (pp. 625-639). Cambridge, MA: MIT Press.
18.
Davidoff, A. L., & Fogarty, L. (1994). Psychogenic origins of multiple chemical sensitivities syndrome: A critical review of the research literature. Archives of Environmental Health, 49, 316-325.
19.
Davis, J. R., Brownson, R. C., Garcia, R., Bentz, B. J., & Turner, A. (1993). Family pesticide use and childhood brain cancer. Archives of Environmental Contamination and Toxicology, 24, 87-92.
20.
Dobkin, P., De Civita, M., Abrahamowicz, M., Bernatsky, S., Schulz, J., Sewitch, M., et al. (2003). Patient-physician discordance in fibromyalgia. Journal of Rheumatology, 30(6), 1326-1334.
21.
Gibbons, A. (1993). Dioxin tied to endometriosis. Science, 262, 13-73.
22.
Gibson, P. R. (1999). Social support and attitude toward health care delivery as predictors of hope in persons with multiple chemical sensitivity. Journal of Clinical Nursing, 8(3), 275-283.
23.
Gibson, P. R. (2003, October). Work experience and accommodation for persons with multiple chemical sensitivity. Paper presented at the Chemical Injury Information Network Chemical Injury Conference, Fairfax, VA.
24.
Gibson, P. R., Cheavens, J., & Warren, M. L. (1996). Chemical sensitivity/chemical injury and life disruption. Women and Therapy, 19(2), 63-79.
25.
Gibson, P. R., Cheavens, J., & Warren, M. L. (1998). Social support in persons with self-reported sensitivity to chemicals. Research in Nursing and Health, 21, 103-115.
26.
Gibson, P. R., Elms, A. N. M., & Ruding, L. A. (2003). Perceived treatment efficacy for conventional and alternative therapies reported by persons with multiple chemical sensitivity. Environmental Health Perspectives, 111, 1498-1504.
27.
Gold, E., Gordis, L., Tonascia, J., & Szklo, M. (1979). Risk factors for brain tumors in children. American Journal of Epidemiology, 109, 309-319.
28.
Goodheart, C. D., & Lansing, M. H. (1996). Treating people with chronic disease: A psychological guide. Washington, DC: American Psychological Association.
29.
Green, J., Romei, J., & Natelson, B. H. (1999). Stigma and chronic fatigue syndrome. Journal of the Chronic Fatigue Syndrome, 5, 63-75.
30.
Guba, E. G., & Lincoln, Y. S. (1994). Competing paradigms in qualitative research. In N. K. Denzin & Y. S. Lincoln (Eds.), Handbook of qualitative research (pp. 105-117). Newbury Park, CA: Sage.
31.
Heuser, G., Wojdani, A., & Heuser, S. (1992). Diagnostic markers of multiple chemical sensitivity. In National Research Council (Ed.), Multiple chemical sensitivities: Addendum to biologic markers in immunotoxicology (pp. 117-138). Washington, DC: National Academy Press.
32.
Hooisma, J., Hanninen, H., Emmen, H. H., & Kulig, B. M. (1994). Symptoms indicative of the effects of organic solvent exposure in Dutch painters. Neurotoxicology and Teratology, 16, 613-622.
33.
Interagency Workgroup on Multiple Chemical Sensitivity. (1998). A report on multiple chemical sensitivity (Predecisional Draft). Retrieved October 1, 2004, from http://www.health.gov/environment/mcs/toc.htm
34.
Kelly, K. S., Soderlund, K., Albert, C., & McGarrahan, A. G. (1999). Social support and chronic fatigue syndrome. Health Communication, 11, 21-34.
35.
Kincheloe, J. L., & McLaren, P. L. (1994). Rethinking critical theory and qualitative research. In N. K. Denzin & Y. S. Lincoln (Eds.), Handbook of qualitative research (pp. 138-157). Newbury Park, CA:Sage.
36.
Kroll-Smith, S., & Floyd, H. H. (1997). Bodies in protest: Environmental illness and the struggle over medical knowledge. New York: New York University Press.
37.
Labor Institute. (1993). Multiple chemical sensitivities at work: A training workbook for working people. New York: Author. (Available from The Labor Institute, 853 Broadway, Room 2014, New York, NY10003)
38.
Lax, M. B. (1998). Multiple chemical sensitivities: The social construction of an illness. International Journal of Health Services, 28, 725-745.
39.
Lax, M. B., & Henneberger, P. K. (1995). Patients with multiple chemical sensitivities in an occupational health clinic: Presentation and follow-up. Archives of Environmental Health, 50, 425-431.
40.
Lehman, A. M., Lehman, D. R., Hemphill, K. J., Mandel, D. R., Cooper, L. M. (2002). Illness experience, depression, and anxiety in chronic fatigue syndrome. Journal of Psychosomatic Research, 52, 461-465.
41.
LeRoy, J., Davis, T. H., & Jason, L. A. (1996). Treatment efficacy: A survey of 305 MCS patients. CFIDS Chronicle, 9(4), 52-53.
42.
Lipson, J. (2001). We are the canaries: Self-care in multiple chemical sensitivity sufferers. Qualitative Health Research, 11, 103-116.
43.
Martinez, J. E., Filho, I. S. B., Kubokawa, K., Pedreire, I. S., Machado, L. A. M., & Cevasco, G. (2001). Evaluation of the quality of life in Brazilian women with fibromyalgia, through the medical outcome survey 36 item short form study. Disability and Rehabilitation, 23(2), 64-68.
44.
Meggs, W. J. (1995a). Multiple chemical sensitivities: Chemical sensitivity as a symptom of airway inflammation. Clinical Toxicology, 33, 107-110.
45.
Meggs, W. J. (1995b). Neurogenic switching: A hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity. Environmental Health Perspectives, 103, 2-4.
46.
Meggs, W. J., Dunn, K. A., Bloch, R. M., Goodman, P. E., & Davidoff, A. L. (1996). Prevalence and nature of allergy and chemical sensitivity in a general population. Archives of Environmental Health, 51, 75-82.
47.
Miller, C. S. (1996). Chemical sensitivity: Symptom, syndrome, or mechanism for disease?Toxicology, 111, 69-86.
48.
Molloy, S. (l992). Measures which will result in greater access for people with environmental illness/multiple chemical sensitivities to California’s publicly-funded facilities: Steps toward regulatory remedies. Unpublished master’s thesis, San Francisco State University, San Francisco.
49.
Morrow, L. A., Ryan, C. M., Hodgson, M. J., & Robin, N. (1991). Risk factors associated with persistence of neuropsychological deficits in persons with organic solvent exposure. Journal of Nervous and Mental Disease, 179(9), 540-545.
50.
Neutra, R., Kreutzer, R., & Lashuay, N. (1999). Prevalence of people reporting sensitivities to chemicals in a population-based survey. American Journal of Epidemiology, 150, 1-11.
51.
Åhman, M., Säderberg, S., & Lundman, B. (2003). Hovering between suffering and enduring: The meaning of living with serious chronic illness. Qualitative Health Research, 13, 528-542.
52.
Pall, M. L. (2003). Elevated nitric oxide/peroxynitrite theory of multiple chemical sensitivity: Central role of N-methyl-D-aspartate receptors in the sensitivity mechanism. Environmental Health Perspectives, 111, 1461-1464.
53.
Paulson, M., Danielson, E., & Säderberg, S. (2002). Struggling for a tolerable existence: The meaning of men’s lived experiences of living with pain of fibromyalgia type. Qualitative Health Research, 12, 238-249.
54.
Price, A. L., Prince, A., & Edsall, P. (200). Quality of life issues for fibromyalgia patients. Arthritis Care and Research, 13(1), 42-50.
55.
Randolph, T. G., & Moss, R. W. (1982). An alternative approach to allergies. New York: Harper and Row.
56.
Schweitzer, R., Kelly, B., Foran, A., Terry, D., & Whiting, J. (1995). Quality of life in chronic fatigue syndrome. Social Science & Medicine, 41, 1367-1372.
57.
Semchuk, K. M., Love, E. J., & Lee, R. G. (1992). ’Parkinsons disease and exposure to agricultural work and pesticide chemicals. Neurology, 42, 1328-1335.
58.
Sherman, J. (1995). Chlorpyrifos (Dursban) associated birth defects: Report of four cases. Archives of Environmental Health, 51, 5-8.
59.
Thornton, J. (1993). Chlorine, human health, and the environment: The breast cancer warning. Washington, DC: Greenpeace.
60.
Tuck, I., & Wallace, D. (2000). Chronic fatigue syndrome: A women’s dilemma. Health Care for Women International, 21, 457-466.
61.
Van Heck, G. L., & De Vries, J. (2002). Quality of life of patients with chronic fatigue syndrome. Journal of Chronic Fatigue Syndrome, 10, 17-35.
62.
Ware, N. C. (1992). Suffering and the social construction of illness: The delegitimization of illness experience in chronic fatigue syndrome. Medical Anthropology Quarterly, 6, 347-361.
63.
Wassen, R. & Hendrix, T. J. (2003). Direct and indirect costs of fibromyalgia to patients and their families. Journal of Orthopaedic Nursing, 7(1), 26-32.
64.
White, R. F., Proctor, S. P., Echeverria, D., Schweikert, J., & Feldman, R. G. (1995). Neurobehavioral effects of acute and chronic mixed-solvent exposure in the screen printing industry. American Journal of Industrial Medicine, 28, 221-231.
65.
Zwillinger, R. (1997). The dispossessed: Living with multiple chemical sensitivities. Paulden, AZ: Dispossessed Project.
